|
12
September 2006
Corporate Focus adds Johnson & Johnson and Reckitt
Benckiser
The ongoing consolidation in the consumer healthcare industry has meant
that there are changes in coverage at Corporate Focus Healthcare.
Coverage of Reckitt Benckiser has been added from Q1 2006. The
acquisition of the Boots Healthcare International brands has transformed
Reckitt Benckiser in the global consumer healthcare market. The
portfolio includes Nurofen, Strepsils and Clearasil as well as Lemsip,
Bonjela and Gaviscon.
Johnson & Johnson has been added from Q3 2006. This reflects the
company’s acquisition of the consumer healthcare brands from Pfizer
during the quarter. The existing Pfizer service will be discontinued
with Q2 2006 the last newsletter published. The brands covered under
Johnson & Johnson include Benadryl, Nicorette, Listerine, Mylanta and
Tylenol.
Corporate Focus Healthcare is designed for companies in the industry as
well as for packaging suppliers, ingredients suppliers and
communications agencies. Subscribers receive four quarterly newsletters
for each company covered as well as the option to receive a detailed
Annual that provides a more detailed strategic and structural analysis
of the company.
Corporate Focus is a division of Through the Loop Consulting. Through
the Loop Consulting is an independent research-based marketing
consultancy. Through the Loop analyses key marketing and branding issues
that affect companies today in a chaotic business environment.
ENDS
For
further information, please contact: Through the Loop Consulting Ltd.
Tel: 01628 898542, fax: 01628 474836, e-mail:
info@throughtheloop.com
|